OSCR Quote, Financials, Valuation and Earnings

The Cigna Group has a net margin of -2.25% compared to Oscar Health's net margin of 1.18%. Oscar Health's return on equity of 2.86% beat The Cigna Group's return on equity of 6.99%.

Oscar Health has a consensus price target of $19.00, signalling upside risk potential of 44.46%. On the other hand The Cigna Group has an analysts' consensus of $395.73 which suggests that it could grow by 41.3%. Given that Oscar Health has higher upside potential than The Cigna Group, analysts believe Oscar Health is more attractive than The Cigna Group.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.504, suggesting its less volatile than the S&P 500 by 49.631%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cigna Group offers a yield of 2% to investors and pays a quarterly dividend of $1.40 per share. Oscar Health pays -- of its earnings as a dividend. The Cigna Group pays out 28.08% of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Oscar Health quarterly revenues are $2.4B, which are smaller than The Cigna Group quarterly revenues of $62.8B. Oscar Health's net income of -$54.6M is lower than The Cigna Group's net income of $739M. Notably, Oscar Health's price-to-earnings ratio is -- while The Cigna Group's PE ratio is 26.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 0.35x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.

Clover Health Investments has a net margin of -2.25% compared to Oscar Health's net margin of -2.77%. Oscar Health's return on equity of 2.86% beat Clover Health Investments's return on equity of -29.15%.

Oscar Health has a consensus price target of $19.00, signalling upside risk potential of 44.46%. On the other hand Clover Health Investments has an analysts' consensus of $4.68 which suggests that it could grow by 46.55%. Given that Clover Health Investments has higher upside potential than Oscar Health, analysts believe Clover Health Investments is more attractive than Oscar Health.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Clover Health Investments has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Clover Health Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health pays -- of its earnings as a dividend. Clover Health Investments pays out -- of its earnings as a dividend.

Oscar Health quarterly revenues are $2.4B, which are larger than Clover Health Investments quarterly revenues of $331M. Oscar Health's net income of -$54.6M is lower than Clover Health Investments's net income of -$9.2M. Notably, Oscar Health's price-to-earnings ratio is -- while Clover Health Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 0.77x for Clover Health Investments. Usually stocks with elevated PS ratios are considered overvalued.

NeueHealth has a net margin of -2.25% compared to Oscar Health's net margin of -24.65%. Oscar Health's return on equity of 2.86% beat NeueHealth's return on equity of -3241.93%.

Oscar Health has a consensus price target of $19.00, signalling upside risk potential of 44.46%. On the other hand NeueHealth has an analysts' consensus of -- which suggests that it could fall by -7.16%. Given that Oscar Health has higher upside potential than NeueHealth, analysts believe Oscar Health is more attractive than NeueHealth.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NeueHealth has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeueHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health pays -- of its earnings as a dividend. NeueHealth pays out -- of its earnings as a dividend.

Oscar Health quarterly revenues are $2.4B, which are larger than NeueHealth quarterly revenues of $232.9M. Oscar Health's net income of -$54.6M is higher than NeueHealth's net income of -$57.4M. Notably, Oscar Health's price-to-earnings ratio is -- while NeueHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 0.06x for NeueHealth. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -2.25% compared to Oscar Health's net margin of 6.11%. Oscar Health's return on equity of 2.86% beat UnitedHealth Group's return on equity of 14.51%.

Oscar Health has a consensus price target of $19.00, signalling upside risk potential of 44.46%. On the other hand UnitedHealth Group has an analysts' consensus of $636.05 which suggests that it could grow by 25.68%. Given that Oscar Health has higher upside potential than UnitedHealth Group, analysts believe Oscar Health is more attractive than UnitedHealth Group.

Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.583, suggesting its less volatile than the S&P 500 by 41.67%.

Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 1.62% to investors and pays a quarterly dividend of $2.10 per share. Oscar Health pays -- of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Oscar Health quarterly revenues are $2.4B, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Oscar Health's net income of -$54.6M is lower than UnitedHealth Group's net income of $6.1B. Notably, Oscar Health's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 32.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 1.21x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.